Concurrently, S&P revised its outlook on Bellin Health to negative from stable.
“The outlook revision reflects our view of Bellin’s proposed growth plans over the coming year, which, if they move forward as expected, could put pressure on the rating,” said S&P credit analyst Allison Bretz.
More articles on healthcare finance:
Highmark Health gifts Penn State Health $25M as part of $1B partnership
7 latest hospital credit downgrades
12 hospitals seeking RCM talent
